Skip to main content

FDA approves Sun’s generic Tessalon


WASHINGTON Sun has received FDA approval for a generic version of Forest Laboratories’ Tessalon capsules, a treatment for coughs due to the common cold, pneumonia and other lung infections.

The company, a week ago, also announced it had received FDA approval for its generic version of Pfizer’s Cerebyx (fosphenytoin sodium), an injectable anticonvulsant that has annual U.S. sales of approximately $15 million.

Brand and generic Tessalon (benzonatate) have annual U.S. sales of approximately $40 million, according to Sun.

This ad will auto-close in 10 seconds